[EN] NITROGEN CONTAINING 2,3-DIHYDROQUINAZOLINONE COMPOUNDS AS NAV1.8 INHIBITORS<br/>[FR] COMPOSÉS 2,3-DIHYDROQUINAZOLINE CONTENANT DE L'AZOTE SERVANT D'INHIBITEURS DE NAV1.8
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2022129281A1
公开(公告)日:2022-06-23
Compounds of formula (I) are described, wherein each of the variable groups is as defined in the specification. Also described are pharmaceutical compositions containing a compound of formula (I), and uses of the compounds and pharmaceutical compositions for inhibiting Nav1.8 voltage-gated sodium channels and treating Nav1.8 mediated diseases, disorders, and conditions, such as pain and pain-associated diseases, disorders, and conditions and cardiovascular diseases, disorders, and conditions, such as atrial fibrillation.
本文描述了公式(I)的化合物,其中每个变量组的定义如规范中所述。还描述了含有公式(I)化合物的制药组合物,以及使用这些化合物和制药组合物来抑制Nav1.8电压门控钠通道并治疗Nav1.8介导的疾病、障碍和病症,如疼痛和与疼痛相关的疾病、障碍和病症以及心血管疾病、障碍和病症,如心房颤动。